Related Experiment Video

Updated: Jun 30, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

Dapsone-induced photosensitivity: a rare clinical presentation

Bikash Ranjan Kar1

  • 1Department of Dermatology, Institute of Medical Sciences & SUM Hospital, Orissa, India. karbikash@yahoo.com

Photodermatology, Photoimmunology & Photomedicine
|September 25, 2008
PubMed

Insights

Dapsone, a key leprosy treatment, can cause rare photosensitivity. This adverse effect, independent of dosage, necessitates awareness in patients with inflammatory skin conditions.

Area of Science:

  • Pharmacology
  • Dermatology
  • Infectious Diseases

Background:

  • Dapsone is a cornerstone anti-inflammatory and antimycobacterial drug used in multidrug therapy (MDT) for leprosy.
  • Its mechanism involves interfering with folate metabolism.
  • Dapsone-induced photosensitivity is a rare, idiosyncratic adverse effect.

Observation:

  • A case of dapsone-induced photosensitivity is reported in an Indian patient diagnosed with leprosy.
  • This adverse event occurred despite dapsone being a standard treatment.

Findings:

  • Dapsone-induced photosensitivity is a rare, non-dose-related adverse effect.
  • The condition can manifest in patients with inflammatory skin disorders, including leprosy.
  • This report adds to the limited documented cases in medical literature.

Implications:

  • Clinicians should be vigilant for photosensitivity reactions in patients treated with dapsone, particularly those with inflammatory skin conditions.
  • Early recognition and management of dapsone-induced photosensitivity are crucial for patient well-being.
  • Further research may elucidate the precise mechanisms and risk factors for this rare adverse effect.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...